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A B S T R A C T
Glucitol-core containing gallotannins (GCGs) are characteristic constituents of the red maple (Acer rubrum)
species. To pursue the development of red maple for nutraceutical applications, GCGs-enriched red maple leaves
extract (MLE) was evaluated for its effects on obesity, gut dysbiosis and short chain fatty acids (SCFAs) pro-
duction. Our results demonstrated that MLE alleviated high-fat diet-induced obesity, reduced body weight gain
and fat mass, improved liver steatosis and insulin resistance, and mitigated adipose hypertrophy and in-
flammation. Additionally, MLE increased total SCFAs, acetic acid and n-butyric acid content, but exerted no
impact on propionic acid production. Moreover, MLE modulated gut microbiota community structure and
certain bacteria relative abundance, including Prevotella and Eubacterium. Our work firstly reports a potential
association between colon-derived SCFAs production and metabolic improvement due to GCGs-enriched red
maple leaves extract administration, and highlights the utilization of red maple gallotannins as a dietary in-
gredient for preventing obesity and related metabolic diseases.
1. Introduction
Obesity is a serious public health burden in several developed
countries because of its high prevalence and huge healthcare cost (Guo,
Liu, Wei, Cheng, & Chen, 2019; McNabney & Henagan, 2017). How-
ever, to date, there are still few effective clinical drugs available to
control overweight and obesity. Hydrolyzable tannins (HTs), including
gallotannins (GTs) and ellagitannins (ETs), are a large group of
polyphenols occurring in plant-derived functional foods, such as ber-
ries, walnuts and pomegranate (Espin, Gonzalez-Sarrias, & Tomas-
Barberan, 2017; Kiss & Piwowarski, 2018). Several studies suggested
that HTs possess antioxidant, anti-inflammatory, anti-diabetic, and
anticancer activities in vitro and in vivo (Smeriglio, Barreca, Bellocco, &
Trombetta, 2017). Additionally, a variety of HTs-rich food or HTs-en-
riched plant extracts have displayed beneficial effects in preventing/
treating obesity and the related metabolic disorders (Fang, Kim, Barnes,
https://doi.org/10.1016/j.jff.2020.103970
Received 17 November 2019; Received in revised form 9 April 2020; Accepted 13 April 2020
Abbreviations: Acc, acetyl-CoA carboxylase; AUC, area under curve; Cebpα, CCAAT enhancer binding protein alpha; CD36, cluster of differentiation 36; Chol,
cholesterol; Cyp7a1, cholesterol 7α-hydroxylase; ETs, ellagitannins; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GCGs, 1,5-anhydro-
glucitol core containing gallotannins; GTs, gallotannins; GTT, glucose tolerance test; HFD, high-fat diet; HMG-CoA Red, HMG-CoA reductase; HMG-CoA Syn, HMG-
CoA synthase; HTs, hydrolyzable tannins; Il-6, interleukin-6; ITT, insulin tolerance test; Ldlr, low-density lipoprotein receptor; LEfSe, linear discriminant analysis
effect size; Mcp1, monocyte chemoattractant protein 1; Mip1α, macrophage inflammatory protein 1α; MLE, red maple leaves extract; NF-κB, nuclear factor kappa B;
OTUs, operational taxonomic units; Pparγ, peroxisome proliferator-activated receptor gamma; PYY, peptide YY; SCFAs, short-chain fatty acids; SD, standard diet;
Srebp1c, sterol regulatory element-binding protein 1c; TG, triglycerides; TNFα, tumor necrosis factor alpha; UPGMA, unweight pair group method with arithmetic
mean; WAT, white adipose tissue
⁎ Corresponding authors at: Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, PR China (J.
Xu).
E-mail addresses: nseeram@uri.edu (N.P. Seeram), xueshihuang@mail.neu.edu.cn (X. Huang), jialin_xu@mail.neu.edu.cn (J. Xu).
1 These two authors contributed equally to this work.
Journal of Functional Foods 70 (2020) 103970
1756-4646/ © 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
Talcott, & Mertens-Talcott, 2018; Heber et al., 2007; Puupponen-Pimia
et al., 2013). Due to the biological effects of plant-derived HTs, in re-
cent years, much attention have been paid to their potential utilization
as functional food ingredients.
Despite their reported health beneficial effects, dietary HTs are
poorly absorbed in the small intestine in their original form, and a large
proportion of ingested HTs would be transported into the colon to be
further metabolized to small phenolic acids by gut microbiota (Kiss &
Piwowarski, 2018). Being an important partner of human cells, gut
microbiota is closely implicated in host energy homeostasis manage-
ment and immunoregulation (Mills, Stanton, Lane, Smith, & Ross,
2019). Components of diet could shape the gut microbiota profile by
generalist and specialized microorganisms or through the cross-feeding
phenomenon (Requena, Martinez-Cuesta, & Pelaez, 2018). Polyphenols,
including HTs, enriched dietary supplements have been reported to
exert prebiotic-like effects through increasing the relative abundance of
some probiotics (Anhe et al., 2015, 2018; Espin et al., 2017; Guo et al.,
2019; Liu et al., 2017). For example, pomegranate ETs treatment re-
markably increased the number of Akkermansia muciniphila (Henning
et al., 2017) and Bifidobacteria spp., and suppressed the growth of
Clostridium bacteria and Staphylococcus aureus in vitro (Bialonska,
Kasimsetty, Schrader, & Ferreira, 2009). Mango peels, abundant in GTs,
showed positive effects on the growth of Bifidobacteria and lactic acid
bacteria in vitro (Sayago-Ayerdi, Zamora-Gasga, & Venema, 2019).
Apart from their influence on gut microbiota community and
structure, HTs may also improve health status by stimulating the se-
cretion of short-chain fatty acids (SCFAs), which are produced by fer-
mentation of undigested food components by microbes in the cecum
and distal colon (Espin et al., 2017). Acetic acid, propionic acid, and n-
butyric acid are the three primary colon-derived SCFAs. SCFAs not only
provide energy for gastrointestinal tract cells, but also act as signaling
molecules directly and/or indirectly impact host metabolism (Canfora,
Jocken, & Blaak, 2015; Ojo et al., 2016). Data suggested that colon-
derived SCFAs play important roles in keeping host energy homeostasis,
modulating the metabolism and function of peripheral tissues (Canfora
et al., 2015; Lu et al., 2016). Increased SCFAs production in gut may
exert beneficial effects on obesity and diabetes management (Flint,
Duncan, Scott, & Louis, 2015). It has been reported that pomegranate
ETs could enhance propionate production in a TWIN-SHIME gastro-
intestinal simulation model (Garcia-Villalba et al., 2017). A recent
study reported that the continuous intake of GTs-rich mango elevated
fecal levels of butyric and valeric acid in lean individuals (Barnes et al.,
2019). Thus, SCFAs, produced by gut microbiota, are regarded as key
factors involved in HTs’ beneficial effects against obesity and the re-
lated metabolic diseases (Kawabata, Yoshioka, & Terao, 2019).
Red maple (Acer rubrum) is a native and important economic maple
species to eastern North America because of its usage to produce maple
syrup (Li & Seeram, 2018). The red maple species has been used in folk
medicine to treat multiple disease, such as sores, back pain, and cough
(Bi et al., 2016). In the course of our group’s interest in developing
nutraceuticals from red maple, we have conducted exhaustive phyto-
chemical investigations on its different plant parts and have isolated
and identified a series of GTs with an uncommon 1,5-anhydro-glucitol
core, named ginnalins and maplexins, polyphenols which are only
produced by some Acer species in the entire plant kingdom (Ma et al.,
2016; Yuan, Wan, Liu, & Seeram, 2012). These 1,5-anhydro-glucitol
core containing gallotannins (GCGs) possess anti-tyrosinase (Ma et al.,
2017), antioxidant, anti-glycation (Ma et al., 2016), anti-hypergly-
caemia effects (Seeram, Xu, Li, & Slitt, 2012), and α-glucosidase en-
zyme inhibiting activities (Wan et al., 2012). However, to date, no data
is available on their potential anti-obesity effects and their underlying
mechanisms of action. Moreover, despite increased attention on the
beneficial effects of HTs-rich dietary supplements, the impact of GCGs
on gut microbiota has not been elucidated.
In the current study, an obese mice model was established by
feeding the mice with a high-fat diet (HFD), and the impact of
supplementation with GCGs-enriched red maple leaves extract (MLE)
on obesity was evaluated by analysing the physiological, histological
and biochemical parameters. 16S rDNA sequencing and GC–MS analysis
were performed to investigate whether MLE supplementation could
reshape the gut microbiota profile thereby affecting colon-derived
SCFAs production in HFD mice.
2. Materials and methods
2.1. MLE preparation and characterization
Red maple leaves were collected from the University of Rhode
Island Kingston campus (RI, USA) as previously reported (Ma et al.,
2017). MLE was prepared according to our previously reported method
(Ma et al., 2017) and its total polyphenol content was determined by
Folin-Ciocalteu method as 62.4% (based on gallic acid equivalents).
The content of the major GCGs present in MLE, namely ginnalins A-C
and maplexin C, were quantified by HPLC-UV method as 47.8, 2.9, 1.3,
and 1.0% (Supporting information Figs. S1 and S2), respectively. The
detailed methodology for HPLC-UV analysis is described in the online
supplementary methods. MLE was available as a dried powder and
dissolved in 20% aqueous 1,2-propanediol before the experiment.
2.2. Dietary intervention study in mice
Male C57BL/6 mice (7-weeks-old, n = 36) were purchased from
Vital River Laboratories (Beijing, China) and housed individually in a
temperature- and humidity-controlled facility. After 1-week acclima-
tion, mice were randomly divided into three groups: Standard diet (SD),
HFD, and HFD+MLE. Mice were fed a standard chow diet (Rat & mouse
maintenance Diet 1025, Beijing HFK Bioscience CO., LTD, Beijing,
China) for SD group, and a high-fat diet for the HFD group (Research
Diets D12492, 60% kcal% fat, Research Diets Inc., New Brunswick, NJ,
USA). For HFD+MLE group, mice were given HFD and supplied with
MLE (dissolved in 20% aqueous 1, 2-propanediol) via oral gavage daily
for 8 weeks. The SD and HFD groups received the same volume of ve-
hicle (20% aqueous 1,2-propanediol). A daily dosage of 150 mg/kg
MLE was selected based on the safety evaluation of MLE by our group
(8 g/kg per day without causing toxicity in mice. Detailed information
provided in Supplementary file “Acute toxicity of MLE in mouse
model”), as well as from a previous animal study conducted with a
ginnalins-enriched extract from Japanese red maple (Acer ginnala)
(Honma, Koyama, & Yazawa, 2011). The human equivalent dose is
estimated to be about 1.2 g/70 kg-adult person/day. During the whole
experiment period, all mice were allowed free access to distilled water
and appropriate diet. Body weight were measured every four days
during the feeding period. Food intake was measured every two days
for four consecutive weeks (from week 5 to week 8). At the end of the
experiment, mice were sacrificed under anesthesia with overdose iso-
flurane. Blood, liver, kidney, white adipose tissue (WAT) and colon
content were collected and stored at −80 °C. All procedures were
conducted in accordance with the National Institutes of Health guide
for the care and use of Laboratory animals (NIH Publications No. 8023,
revised 1978) and were approved by the Northeastern University An-
imal Care and Use Committee (Shenyang, China) with a license number
NEUACUC2016012.
2.3. Glucose and insulin tolerance test
Intraperitoneal glucose tolerance test (GTT) was performed at the
beginning of week 6. Mice were fasted 6 h and then given a single dose
of glucose (2 g/kg body weight) by intraperitoneal injection. Blood
glucose levels was determined by measuring tail blood at 0, 15, 30, 60,
and 120 min post glucose administration with a glucometer (Bioland
Technology, Shenzhen, China). At the end of week 6, insulin tolerance
test (ITT) was conducted. Mice were fasted 5 h before receiving an
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intraperitoneal injection of insulin (0.75 U/kg body weight). The blood
glucose contents were measured at 0, 15, 30, 60, and 120 min. AUC
(area under curve) value was calculated for each group.
2.4. Histological analysis
A portion of liver and subcutaneous WAT were fixed in 4% neutral-
buffered formalin and then embedded in paraffin. Tissue sections
(5 μm) were stained with hematoxylin and eosin (H/E) before histo-
pathologic analysis. Frozen liver sections were stained with Oil Red O
solution (Oil Red O stock solution: H2O, 6:4; Oil Red O stock solution
was 0.5% Oil Red O in isopropanol). Five fields for each WAT section
were analyzed to determine the average size and numbers of adipocytes
in each experimental group (n = 4 per group). The pathological
changes were photographed using a manual inverted system micro-
scope (LEICA DMI3000 B, Leica Biosystems, Wetzlar, Germany).
2.5. Physiological and biochemical parameters measurement
In the middle of week 8, mice were food deprived overnight with
free access to water. Blood samples were collected from the tail vein
and serum were extracted. Insulin levels were measured using a mouse
insulin ELISA kit according to manufacturer’s instructions (R&D
System, Minneapolis, MN, USA). Glucose, triglycerides (TG) and cho-
lesterol (Chol) content were determined with the reagent kits purchased
from Nanjing Jiancheng Biomedical Company (Nanjing, China). Free
fatty acid (FFA) content was determined with the reagent kit from
Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Hepatic lipid was
extracted from liver tissues with chloroform-methanol method as pre-
viously reported (Xu et al., 2018). Hepatic TG, FFA, and Chol content
were determined with the described reagent kits. Tumor necrosis factor
alpha (TNFα) content in WAT was measured using a mouse TNFα ELISA
kit (BD Biosciences, San Jose, CA, USA). HOMA-IR was calculated as
follows: HOMA-IR = fasting insulin (mU/L) × fasting glucose (mM)/
22.5 (Matthews et al., 1985).
2.6. Quantitative real-time polymerase chain reaction
Total RNA were extracted from liver and subcutaneous WAT by
using Trizol reagent according to the manufacturer’s instructions
(Thermo Scientific, Grand Island, NY, USA). Two micrograms of total
RNA was reversely transcribed to cDNA. The relative mRNA levels were
determined with a CFX96 Touch™ Real-Time PCR Detection System
(Bio-Rad Laboratories, Hercules, CA, USA). Reaction conditions were as
follows: 10 min at 95 °C, followwed by 45 cycles of 10 s at 95 °C, 20 s at
60 °C, and 20 s at 72 °C. SYBR green chemistry was used. The used
primer sequences are listed in Supplementary Table S1.
2.7. Western blot analysis
Homogenate from liver or WAT were resolved by SDS-PAGE and
then transferred to PVDF membrane. The membrane was blocked with
5% non-fat dry milk in TBST followed by incubation with primary
antibodies at 4 °C overnight. After washing with TBST, the membranes
were incubated with secondary antibody for 1 h at room temperature.
The images were captured with Bio-Rad ChemiDoc™ imaging systems.
The antibodies of acetyl-CoA carboxylase (Acc), p-Acc, peroxisome
proliferator-activated receptor gamma (Pparγ), fatty acid synthase
(Fas), nuclear factor kappa B (NF-κB), and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) were obtained from Cell Signaling
Technology (Danvers, MA, USA).
2.8. Short-chain fatty acids (SCFAs) analysis
The acetic acid, propionic acid and n-butyric acid in colon content
were determined on a Shimadzu GCMS-QP2020 gas chromatograph
mass spectrometer (Shimadzu Corporation, Kyoto, Japan) equipped
with an AOC-20i auto injector (Shimadzu Corporation), and an
InertCap WAX capillary column (30 m × 0.32 mm × 0.25 μm; GL
Sciences Inc., Tokyo, Japan). The standards of acetic acid, propionic
acid, n-butyric acid, and 2-ethylbutyric acid were purchased from
Sigma-Aldrich (St. Louis, MO, USA). The detailed SCFAs extraction and
programmed temperature for the GC–MS analysis were performed ac-
cording to previously reported method (Xu et al., 2019). Each analysis
was repeated three times individually.
2.9. Gut microbiota analysis
Fecal samples for each mouse were collected at the end of week 8.
Since the fecal amount from each mouse weighed far less than 200 mg,
especially for the HFD treated mice, the fecal samples from 4 mice in
each group were randomly pooled to yield a total of nine samples (fecal
weight ≥ 200 mg per sample) for microbiome analyses (n = 3 per
group). Bacterial genomic DNA was extracted by using QIAamp DNA
stool Mini Kit from Qiagen (Hilden, Germany) according to the manu-
facturer’s instructions. The 16S rDNA of V3-V4 regions was amplified
by PCR using the universal primers 341F (5′-CCTAYGGGRBGCAS-
CAG-3′) and 806R (5′-GGACTACNNGGGTATCTAAT-3′). The amplified
products were purified by 2% agarose gel electrophoresis and AxyPrep
DNA Gel Extraction Kit (Axygen Biosciences, Union City, CA, USA).
High-throughput pyrosequencing of the PCR products was performed
by Realbio Technology Co, Ltd (Shanghai, China) on an Illumina HiSeq
PE250 platform. USEARCH was used to pick out operational taxonomic
units (OTUs) based on a ≥97% sequence similarity (Edgar, 2013).
Taxonomic annotation of representative sequence of each OTU were
conducted based on the RDP database at an 80% confidence level (Liu
et al., 2017). QIIME software was used for alpha diversity analysis. The
Unweight Pair Group Method with Arithmetic mean (UPGMA) clus-
tering based on weighted UniFrac distances were performed to de-
termine difference between metagenomic samples. Linear discriminant
analysis effect size (LEfSe) was used to identify biomarker species in
different groups with a threshold more than 3.
2.10. Statistics
Quantitative data were presented as mean ± SE. One-way analysis
of variance (ANOVA) with Student-Newman-Keuls post hoc test was
used to assign significance to the difference between groups. Wilcoxon
rank sum test were conducted to identify the microbiota that were
significantly different between two groups, and Kruskal-Wallis test were
used to detect the differences of fecal microbiota among three groups.
The difference was considered significant if P < 0.05.
3. Results
3.1. MLE alleviated high-fat diet-induced obesity in mice
As shown in Fig. 1A, HFD feeding significantly increased body
weight (increased by 30% than SD mice). Liver weight, kidney weight,
as well as epididymal, perirenal, subcutaneous, and visceral WAT mass
were all increased in HFD mice than in SD mice (Table 1). MLE ad-
ministration significantly reduced the effects upon HFD feeding. Com-
pared to HFD-fed controls, body weight gain was decreased by 37% in
HFD+MLE mice (Fig. 1B), along with reduced liver weight, kidney
weight, and different types of WAT mass (Table 1), suggesting that MLE
administration prevented HFD-induced obesity in mice. In addition, no
difference in energy intake was determined among these three groups,
suggesting that the reduced obesity in MLE-treated mice was not due to
decreased energy intake (Fig. 1C).
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3.2. MLE ameliorated high-fat diet-induced liver steatosis and hepatic
inflammation
Diet-induced obesity is usually accompanied by ectopic lipid accu-
mulation in liver (Guo et al., 2019). In the current study, MLE sup-
plementation alleviated HFD-induced liver steatosis, evidenced by
amelioration of hepatic lipid accumulation from H/E staining and Oil
red O staining (Fig. 2A), and significantly reduced hepatic TG (by 25%)
and FFA (by 32%) levels in HFD+MLE mice livers (Fig. 2B). No dif-
ference in hepatic Chol was determined between HFD and HFD+MLE
mice. The mRNA levels of genes related to lipogenesis and fatty acid
synthesis, including Pparγ, sterol regulatory element-binding protein 1c
(Srebp1c), Acc, Fas, and cluster of differentiation 36 (CD36), were de-
creased in HFD+MLE mice than in HFD mice (Fig. 2C). Decreased
protein levels of Pparγ, Acc, and Fas in HFD+MLE mice confirmed the
anti-lipogenesis effects of MLE (Fig. 2D). Additionally, the mRNA levels
of HMG-CoA synthase (HMG-CoA Syn), HMG-CoA reductase (HMG-CoA
Red), low-density lipoprotein receptor (Ldlr), and cholesterol 7α-hy-
droxylase (Cyp7a1), which are responsible for cholesterol synthesis,
endocytosis, and the conversion of cholesterol to bile acid (Tu et al.,
2019), were reduced in MLE-treated mice (Fig. 2C). Visceral obesity
increases pro-inflammatory cytokines secretion, leads to insulin re-
sistance and further adiposity (Liu et al., 2017). In the current study,
the mRNA levels of monocyte chemoattractant protein 1 (Mcp1), in-
terleukin-6 (Il-6), Il-1β, and macrophage inflammatory protein 1α
(Mip1α), were reduced in HFD+MLE mice than in HFD-fed controls,
along with insignificant decrease of TNFα mRNA levels (Fig. 2E). These
results suggested that HFD-induced inflammation was reduced by MLE
administration in mice livers.
3.3. MLE attenuated HFD-induced white adipose tissue expansion and
inflammation
Obesity has been previously reported to cause adipocyte expansion
and local low-grade inflammation (Liu et al., 2017). As shown in
Fig. 3A, HFD-feeding increased lipid accumulation in WAT and pro-
moted adipocyte expansion, but the induction was robustly abolished
by MLE supplementation. Further analysis of the mean size of adipo-
cytes demonstrated that there were more smaller adipocytes in HFD
+MLE mice than in HFD-fed controls (Fig. 3B). Almost 50% of adipo-
cytes in HFD-fed controls possessed large size (> 15,000 μm2), while
the frequency of small adipocytes (1000–7000 μm2) was much higher in
HFD+MLE group (> 80%) than in HFD control (< 30%) (Fig. 3C),
suggesting that MLE treatment prevents adipocyte hypertrophy and
expansion. Increased lipid accumulation in WAT is associated with
hypertrophy, due to increased adipogenesis, related with the induction
of adipogenic transcription factors, including CCAAT enhancer binding
protein alpha (Cebpα) and Pparγ. MLE-treatment significantly reduced
the mRNA and protein levels of Cebpα and Pparγ in WAT of HFD+MLE
mice, reduced adipogenesis process and prevented lipid accumulation
(Fig. 3D and 3G). Importantly, MLE administration fully prevented
HFD-induced adipose tissue inflammation, as evidenced by reduced
mRNA levels of IL-6 and Il-1β (Fig. 3E), as well as by the decreased NF-
κB protein level (Fig. 3G). Additionally, the protein level rather than
mRNA level of TNFα were obviously reduced in MLE treated mice
(Fig. 3F).
3.4. MLE alleviated high-fat diet-induced insulin resistance
We next determined the influence of MLE supplementation on glu-
cose homeostasis management and insulin sensitivity. HFD feeding in-
duced fasting hyperglycemia and hyperinsulinemia, and increased
HOMA-IR index than in SD mice (by 436%). MLE administration sig-
nificantly reduced fasting plasma glucose and insulin levels in HFD
mice, suggesting improved insulin sensitivity in MLE-treated mice. This
conclusion was supported by the observed reduced HOMA-IR index
(reduced by 42%) in HFD+MLE mice compared to HFD mice (Fig. 4A).
GTT and ITT assays demonstrated significant lower glucose levels in
HFD+MLE mice than in HFD mice at all measured time point, along
with lower AUC values, revealed the positive roles of MLE supple-
mentation on modulating glucose homeostasis and insulin sensitivity
(Fig. 4B and C).
3.5. MLE modulated colon SCFAs production in mice
To evaluate the impact of MLE supplementation on gut microbiota
metabolism, the SCFAs content in colonic fecal samples were de-
termined by GC–MS method. Total SCFAs, acetic acid, propionic acid,
and n-butyric acid were all significantly reduced after HFD treatment
(P < 0.05). MLE supplementation reversed HFD-induced reduction
and remarkably increased the content of total SCFAs, acetic acid and n-
butyric acid, with no impact on propionic acid production in HFD mice
(Fig. 5A–D). Additionally, the relative abundance of n-butyric acid in
the colon fecal samples of HFD+MLE mice was almost two fold as that
of HFD-fed controls (increased from 5.8% in HFD mice to 11.8% in HFD
+MLE mice) (Fig. 5E).
Fig. 1. MLE alleviated high-fat diet-induced obesity in mice. Eight-weeks-old
C57BL/6 mice were fed either a standard chow diet (SD) or high-fat diet (HFD)
for 8 weeks. HFD+MLE mice were administered with MLE with a dose of
150 mg/kg by oral gavage daily. (A) The body weight curve of mice upon MLE
administration. (B) The body weight gain and (C) energy intake for the three
groups of mice. n = 12 for each group. Data were expressed as mean ± SE. *,
P < 0.05, HFD vs. SD group. #, P < 0.05, HFD+MLE vs. HFD group.
Table 1
Body weight and organ weight in SD, HFD, and HFD+MLE groups of mice
(unit: g).
Parameter SD HFD HFD+MLE
Body weight 26.62 ± 0.39 33.83 ± 0.64*** 29.88 ± 0.62###
Liver weight 1.19 ± 0.02 1.29 ± 0.040.028 1.19 ± 0.030.024
Kidney weight 0.33 ± 0.01 0.35 ± 0.010.009 0.33 ± 0.010.042
Heart weight 0.13 ± 0.00 0.14 ± 0.010.125 0.13 ± 0.000.147
Total WAT weight 0.98 ± 0.08 3.66 ± 0.14*** 2.37 ± 0.21###
Epididymal WAT
weight
0.36 ± 0.03 1.63 ± 0.07*** 0.98 ± 0.08###
Perirental WAT weight 0.14 ± 0.02 0.75 ± 0.04*** 0.47 ± 0.04###
Subcutaneous WAT
weight
0.26 ± 0.02 0.79 ± 0.03*** 0.59 ± 0.050.001
Visceral WAT weight 0.19 ± 0.02 0.49 ± 0.02*** 0.33 ± 0.04###
*** P < 0.001, HFD vs. SD group.
### P<0.001, HFD+MLE vs. HFD group.
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3.6. MLE reshaped gut microbiota profile upon high-fat diet treatment
Based on the increased n-butyric acid production in MLE-treated
mice, we further investigated the effects of MLE supplementation on gut
microbiota profile. As shown in Fig. 6A, a total of 527 OTU were
clustered from three groups of fecal samples by high-throughput se-
quencing of the bacterial 16S rDNA V3-V4 region. No significant dif-
ference was found for α-diversity analysis of index of Shannon, Chao1
and the observed species among these three groups (data not shown).
The UPGMA clustering suggested significant impact of HFD feeding and
MLE supplementation on gut microbiota profile (Fig. 6B). To identify
the key phenotypes that were significantly altered due to MLE supple-
mentation, LEfSe and heatmap analysis were conducted. As shown in
Fig. 6C and 6D, in HFD-fed controls, microbiota in the Firmucutes
phylum were enriched, whereas, the Bacteroidetes phylum, Porphyr-
omonadaceae and Prevotellaceae family, and Prevotella genus were de-
creased when compared to SD group. MLE supplementation leads to
significant recovery for the above microbiota mentioned. Notably, the
relative abundance of Eubacterium genus in HFD+MLE mice was the
highest one among these three groups (Fig. 6E).
4. Discussion
A growing body of data support that consumption of HTs-rich food
or their derived nutraceuticals are effective dietary intervention stra-
tegies to prevent and/or treat diet-induced obesity (Heber et al., 2007;
Fig. 2. MLE ameliorated high-fat diet-induced liver steatosis and hepatic inflammation. (A) Representative photos of haematoxylin and eosin (H/E) staining (up) and
Oil Red O staining (down) of livers from SD, HFD, and HFD+MLE mice (scale bar = 50 µm). n = 4 for each group. (B) Hepatic triglycerides (TG), free fatty acid
(FFA), and cholesterol (Chol) were measured in three groups of mice. n = 8 for each group. Total RNA was extracted from liver tissues, and the mRNA levels were
determined by real-time PCR. The relative mRNA levels have been normalized with 18S rRNA levels. (C) The transcriptional levels of genes related to lipogenesis and
cholesterol metabolism were determined in three groups of mice. n = 6 to 7 for each group. (D) Immunoblot analysis of the protein levels of Pparγ, Fas, p-Acc, Acc in
livers of SD, HFD, and HFD+MLE mice. GAPDH was used as a loading control. (E) The transcriptional levels of genes related to hepatic inflammation were
determined in three groups of mice. Data were expressed as mean ± SE. *, P < 0.05, HFD vs. SD group. #, P < 0.05, HFD+MLE vs. HFD group.
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Kiss & Piwowarski, 2018; Puupponen-Pimia et al., 2013). The red maple
is abundant in GCGs, an uncommon type of GTs containing a 1,5-an-
hydro-glucitol core (Ma et al., 2017; Wan et al., 2012; Yuan et al.,
2012). To pursue the development of red maple leaves as a
nutraceutical, in the current study, we evaluated the anti-obesity effects
of a GCGs-enriched red maple leaves extract (MLE) in HFD-fed mice.
The present study demonstrated for the first time that GCGs-enriched
MLE supplementation could effectively attenuate HFD-induced obesity,
Fig. 3. MLE attenuated HFD-induced white adipose tissue expansion and inflammation. (A) H/E staining of subcutaneous white adipose tissue sections (scale bar:
50 μm). (B) Mean size of adipocytes and (B) the frequency of adipocyte size distribution in each group (n = 4 per group, at least 400 adipocyte area were counted for
each group). (D) The transcriptional levels of adipogenic markers of Cebpα and Pparγ were measured by real-time PCR analysis. (E) The transcriptional levels of
inflammatory markers of Il-6, Il-1β, and TNFα were measured by real-time PCR analysis. (F) TNFα protein levels in white adipose tissue were determined by ELISA
assay. (G) Immunoblot analysis of Cebpα, Pparγ and NF-κB in white adipose tissue of three groups of mice. Data were expressed as mean ± SE. *, P < 0.05, HFD vs.
SD group. #, P < 0.05, HFD+MLE vs. HFD group.
L. Li, et al. Journal of Functional Foods 70 (2020) 103970
6
modulate gut microbiota community and promote colon-derived n-bu-
tyric acid production.
Growing evidence suggests that polyphenols could impact the
community of gut microbiota and its metabolites (Anhe et al., 2015;
Bialonska et al., 2009; Espin et al., 2017). Being metabolites of gut
microbes, SCFAs possess a wide range of positive effects both within
and outside the gut (Morrison & Preston, 2016; Zeng, Umar, Rust,
Lazarova, & Bordonaro, 2019). Although the relationship between en-
ergy harvesting and colonic microbiota-related SCFAs production is
largely unknown, published data have demonstrated that SCFAs sup-
plementation could increase the expression of thermogenesis-related
genes and proteins thereby increase energy expenditure without im-
pacting energy intake (Canfora et al., 2015). Several studies have re-
ported that polyphenols could reverse HFD-induced body weight gain
and related metabolic disorders without reducing energy intake but by
increasing energy expenditure (Anhe et al., 2018; Mele et al., 2017; Tu
et al., 2019). In addition, certain SCFAs are reported to be capable of
stimulating the excretion of anorexic hormones in the intestine, such as
peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), which play
important roles in body weight control via the gut-brain axis (Anhe
et al., 2015). However, the exact impact of SCFAs on anorexic hor-
mones excretion and energy intake are still not clear. A short-term
human study with oligofructose supplementation at high dosage pro-
moted SCFAs production in the colon and increased peptide YY (PYY)
excretion but exerted no impact on energy intake (Pedersen et al.,
2013). In the current study, reduced body weight gain and fat accu-
mulation, and increased fecal SCFAs content were observed in HFD
+MLE mice when compared to HFD mice, with no difference in energy
intake between the two groups. Further studies to investigate the im-
pact of MLE administration on energy expenditure and anorexic hor-
mones excretion would be helpful for elucidating the mechanisms that
are involved in the potential anti-obesity effects of MLE.
Besides intestinal mechanisms, SCFAs could directly affect substrate
metabolism and function in peripheral tissues by activating certain
signaling pathway after binding to their natural receptors (Canfora
et al., 2015). A previous study revealed that Pparγ was a key mediator
of dietary SCFAs supplementation induced anti-obesity effects in HFD-
fed mice. SCFAs supplementation-induced decreased Pparγ expression
in hepatic and adipose tissue led to the switch from lipid synthesis to
utilization in both tissues, therefore alleviating HFD-induced hepatic
steatosis, body weight gain and insulin resistance (den Besten et al.,
2015). In the current study, higher total SCFAs, acetic acid and n-bu-
tyric acid (P < 0.05) content were detected in colon fecal samples of
MLE-treated mice compared to HFD-fed controls, along with no influ-
ence on the propionic acid content. Furthermore, a significant de-
creased Pparγ expression was detected in both hepatic and adipose
tissues in the MLE-treated mice compared to the HFD-fed control mice.
Our data suggested that the anti-obesity effects of MLE might be due to,
in part, increased SCFAs production via a Pparγ-dependent pathway.
Among colon-derived SCFAs, n-butyric acid has attracted the most
Fig. 4. MLE alleviated high-fat diet-induced insulin
resistance. Mice were gavaged with MLE for
8 weeks, and then were fasted overnight. (A) The
blood glucose and (B) insulin concentration were
measured in SD, HFD, and HFD+MLE groups. (C)
HOMA-IR index was calculated for each group.
n = 6 for each group. (D) Glucose tolerance test
(GTT) was performed on mice 6 weeks post MLE
administration (left panel). Mice were fasted 6 h,
and then mice were challenged with glucose (2 mg/
kg body weight) intraperitoneally. The blood glu-
cose content was measured by tail bleeding 0, 15,
30, 60, and 120 min post glucose administration.
AUC value was calculated for each group (right
panel). (E) Insulin tolerance test (ITT) was per-
formed on mice 6 weeks post MLE administration
(left panel). Mice were fasted for 5 h, and then mice
were challenged with insulin (0.75 U/kg body
weight) intraperitoneally. The blood glucose con-
tent was measured by tail bleeding 0, 15, 30, 60,
and 120 min post insulin administration. AUC
value was calculated for each group (right panel).
n = 6 to 7 per each group. Data were expressed as
mean ± SE. *, P < 0.05, HFD vs. SD group. #,
P < 0.05, HFD+MLE vs. HFD group.
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attention because of its important role not only in providing energy for
gut epithelial cells, but also in modulating host energy metabolism and
immune reaction (McNabney & Henagan, 2017). Previous studies have
shown that supplementation of butyrate could down-regulate cytokines
and immunological markers in adipose tissue of db/db mice (Wang
et al., 2015), and liver of HFD-fed obese rats (Mattace Raso et al.,
2013). In the current study, the relative abundance of n-butyric acid in
the MLE group (11.8%) was more than two folds of that in HFD-fed
controls (5.8%). Our result was consistent with a previous study which
reported that GTs-rich mango supplementation for 6 weeks was capable
of enhancing n-butyric acid production in humans (Barnes et al., 2019).
Concomitantly, the inflammation in liver and adipose tissues, induced
by HFD feeding, were decreased upon MLE supplementation, as re-
vealed by reduced Il-6, Il-1β, TNFα, Mcp1, and Mip1α gene expression,
along with NF-κB protein expression. Although we did not directly
establish the casual relationship between MLE-induced increase of n-
butyric acid production and the improved features of metabolic syn-
drome in MLE-treated HFD-fed mice, several studies have reported that
oral supplementation of sodium butyrate could significantly attenuate
body weight gain, liver steatosis and inflammation, as well as insulin
resistance in HFD-fed animals (Fang, Xue, Chen, Chen, & Ling, 2019;
Gao et al., 2009; Matheus, Monteiro, Oliveira, Maschio, & Collares-
Buzato, 2017; Mattace Raso et al., 2013). A recent report indicated that
butyrate, not propionate, was associated with reduced T2D risk (Sanna
et al., 2019). Thus, the anti-obesity effect displayed by MLE, could be
attributed, at least in part, to its effects on butyric acid production.
Different phylogenetic groups of bacteria are responsible for
acetate, propionate, and butyrate production in the gut. Many bacterial
groups, such as Prevotella spp., Bacteroides spp., Bifidobacterium spp.
could produce acetate (Zeng et al., 2019). Interestingly, in the current
Fig. 5. MLE modulated colon SCFAs production in mice. Colon content for each mouse were collected at the end of week 8, and every two fecal samples in each group
were randomly selected and pooled (fecal weight ≥ 200 mg per sample) for SCFAs analyses with GC–MS. The amount of (A) total SCFAs, (B) acetic acid, (C)
propionic acid, and (D) n-butyric acid in three groups of mice. (E) The relative abundance of acetic acid, propionic acid, and n-butyric acid in fecal samples of three
groups of mice. n = 6 per group. Data were expressed as mean ± SE. *, P < 0.05, HFD vs. SD group. #, P < 0.05, HFD+MLE vs. HFD group.
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study, we observed increased relative abundance of Prevotella genus in
MLE-treated mice compared to the HFD-fed control mice. This may
explain the enhanced acetic acid level in colon fecal samples of the MLE
group. The bacteria colonize in human gut as butyrate producers were
specified. Among identified butyrate-producing bacteria, Eubacterium
spp have attracted a lot of attention because of their relative high
abundance (McNabney & Henagan, 2017). Consuming resistant starch-
like diet has been reported to enhance the butyrate production in colon
through impacting the relative abundance of Eubacterium (Tanaka,
Yamamoto, Yamada, Furuya, & Uyeno, 2016). In the current study, the
Fig. 6. MLE reshaped gut microbiota upon high-fat diet treatment. Fecal samples for each mouse were collected at the end of week 8, and three fecal samples in each
group were submitted for microbiome analyses. (A) Venn disgram shows the OUT distribution of fecal microbiota from three groups of mice. (B) Clutster analysis
based on weighted Unifrac distance. (C) LDA scores of the differently abundant taxa in fecal microbiota from three groups of mice. (D) Heatmap of relative abundance
of bacterial taxa in faeces from the three groups of mice. (E) Relative abundance of Prevotella and Eubacterium genus obtained in fecal microbiota from three groups of
mice. n = 3 per group. *, P < 0.05, HFD vs. SD group. #, P < 0.05, HFD+MLE vs. HFD group.
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relative abundance of Eubacterium was elevated in the MLE treated
group compared to the untreated HFD-fed mice, suggesting that MLE
supplementation promotes the growth of Eubacterium. The pH of the
proximal colon affects the community and activity of gut microbiota,
and play an important role in butyrate production (Louis & Flint, 2009).
Butyrate-producing bacterial thrive at mildly acidic pH condition at
5.5, not pH 6.5 (Walker, Duncan, McWilliam Leitch, Child, & Flint,
2005). A previous study with GTs-enriched food suggested that GTs
would be metabolized to low molecular weight phenolic acids, such as
gallic acid and 4-O-methyl gallic acid, through enzymatic degradation
(Kiss & Piwowarski, 2018). Although the metabolites of GCGs in vivo are
not known, considering the similarity in chemical structure of GCGs
with other GTs, MLE may also affect the pH of the colon via GCGs’
metabolites thereby increasing the relative abundance of Eubacterium,
and enhanced butyrate production. Further studies to investigate the
microbial metabolites of GCGs are warranted to better understand the
anti-obesity effects of MLE. While the pooling of fecal samples from
multiple animals for 16S rDNA analysis is a limitation of the current
study, this has allowed for the evaluation of the shifts of the main
phylotypes due to the different treatments. Further studies on the im-
pact of pure GCGs supplementation on gut microbiota community with
more animals are warranted to better understand the relationship be-
tween anti-obesity effects of GCGs and gut microbiota and their by-
product SCFAs.
It is well known that principal SCFAs are derived from the fer-
mentation of indigestible dietary components by gut microbe (Canfora
et al., 2015). Polyphenols have been reported to manage energy
homeostasis via regulating nutrients digestion and absorption. Green
tea polyphenols have been found capable of inhibiting pancreatic lipase
activity, which enables the reduction of lipid digestion and absorption
in obese mice (Seo et al., 2017). Although we did not measure the ef-
fects of MLE on digestive enzymes in the current study, 2-O-digalloyl-
1,3,4,6-tetra-O-galloyl-β-D-glucose, a gallotannin from Galla rhois
showed potent inhibitory effects against pancreatic lipase with IC50
value of 3.5 μM (Kwon et al., 2013). Our previous work has revealed
that GCGs could significantly inhibit the activity of α-glucosidase (Wan
et al., 2012), which plays an important role in carbohydrates digestion
and absorption in the small intestine. As major components of MLE,
GCGs possess putative inhibitory effects against carbohydrate digestion
and absorption in the gastrointestinal tract, thereby promoting more
undigested carbohydrates entering colon and impacting microbe and its
metabolic products SCFAs. Similar effects against other digestive en-
zymes might also be involved in protein and/or lipid absorption in MLE
treated mice. The relationship between increased SCFAs production and
the inhibitory effects of MLE on nutrient digestion and absorption are
not clear. Further in vivo studies to investigate the impact of MLE ad-
ministration on ingredients in the fecal matter, such as the undigested
sugars, proteins, and lipids would help increase scientific understanding
of the underlying mechanism of anti-obesity effects of MLE, and would
be pursued by our group in the future.
5. Conclusion
In conclusion, our data demonstrated that dietary GCGs-enriched
red maple leaves extract could alleviate body weight gain and insulin
resistance, reduce fat mass and hepatic lipid ectopic accumulation, as
well as ameliorate liver and white adipose tissue inflammation in HFD-
fed mice. These beneficial effects are proposed, at least partially, to be
due to the modulation of the relative abundance of butyrate- and
acetate- producing bacteria. The effects of MLE on other gut microbiota
metabolites and the nutrient absorption and excretion warrant further
investigation.
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